维普期刊资源整合服务平台（V6.5）

39篇 您的检索式：作者名="KARLAN B"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma显示文摘	McIntosh MW Drescher C Karlan B	2004	Gynecol Oncol2004，95，：	1
2	Estrogen and progesterone receptor subtype expression in normal and malignant ovarian epithelial cell cultures显示文摘	Li A J Baldwin R L Karlan B Y	2003	Am J Obstet Gynecol2003，189，1：	1
3	Ovarian cancer:the duplicity of CA125 measurement显示文摘	Karam A K Karlan B Y	2010	Nat Rev Clin Oncol2010，7，6：	1
4	Combining CA125 and SMR serum markers for diagnosis and early detection of ovarian carci- noma 显示文摘	McIntosh MW Drescher C Karlan B	2004	Gynecologic Oncology2004，95，1：	1
5	Ovarian cancer: the duplicity of CA125 measurement 显示文摘	Karam A K Karlan B Y	2010	Nat Rev Clin Oneol2010，7，6：	1
6	Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer:Evidence supporting a mesothelial-toepithelial transition显示文摘	Bendoraite A Knouf E C Garg K S Parkin R K Kroh E M O'Briant K C Ventura A P Godwin A K Karlan B Y Drescher C W and others		0，，01：	1
7	Quality of care in advanced ovarian cancer : the importance of provider specialty显示文摘	Mercado C Zingmond D Karlan B Y	2010	Gynecol Oncol2010，117，1：	1
8	Ovarian cancer:the duplicity of CA125 measurement显示文摘	Karam A Karlan B	2010	Nat Rev Clin Oncol2010，7，6：	1
9	Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma 显示文摘	Mcintosh M W Drescher C Karlan B	2004	Gyneeol Oncol2004，95，1：	1
10	Combining CA125 and SMR serum markers for diagnosis and early detection of ovarian carci-noma显示文摘	McIntosh MW Drescher C Karlan B		0，，：	1
11	Combining CA125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma显示文摘	MCINTOSH M W DRESCHER C KARLAN B	2004	Gynecol Oncol2004，95，1：	1
12	Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma 显示文摘	Mclntosh MW Drescher C Karlan B	2004	Gynecol Oncol2004，95，1：	1
13	Combining CA125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma显示文摘	McIntosh MW Drescher C Karlan B	2004	Gynecol Oncol2004，95，1：	1
14	Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer risk显示文摘	Walsh C S Miller C W Karlan B Y	2007	Gynecol Oncol2007，104，3：	1
15	BRCA1 promoter methylation predicts adverse ovarian cancer prognosis显示文摘	Chiang J W Karlan B Y Cass L	2006	Gynecologic Oncology2006，101，：	1
16	Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma显示文摘	McIntosh MW Drescher C Karlan B	2004	Gynecol Oncol2004，95，1：	1
17	Chemotherapy in epithelial ovarian cancer 显示文摘	Wang J Li A J Karlan B Y	2002	Current Women''s Health Reports2002，2，1：	1
18	Randomized,doubleblind ,placebocontrolled phase D study of AMG 386 combined with weekly paclitaxel in patients ( pts) with recurrent ovarian carcinoma显示文摘	Karlan B Y Oza A M Richardson G E	2010	J Clin Oncol2010，28，：	1
19	Ovarian cancer: the duplicity of CA125 measurement 显示文摘	Karam A K Karlan B Y	2010	Nat Rev Clin Oncol2010，7，6：	1
20	Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma显示文摘	McIntosh MW Drescher C Karlan B	2004	Gynecol Oncol2004，95，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示